We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Severe community-acquired pneumonia: Severity and management.
- Authors
Liapikou, Adamantia; Cilloniz, Catia
- Abstract
Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality worldwide. "Severe CAP" (sCAP) identifies a group of patients who have severe disease and require Intensive Care Unit admission. Recommendations for antibiotic treatment for sCAP are based on illness severity, frequency of specific pathogens and local microbial resistance patterns. The challenges to patient management include the emergence of the high prevalence of multidrug-resistant in CAP, mainly from institutionalizing patients. A new approach is the evaluation of biomarkers as C-reactive protein, procalcitonin on the diagnosis, prognosis and therapy duration of sCAP with promising results. Implementation of guidelines for CAP treatment should be emphasized in order to increase survival. The benefits of steroid use in patients with severe pneumonia have not been proven yet by current literature.
- Subjects
COMMUNITY-acquired pneumonia; INTENSIVE care units; C-reactive protein; MULTIDRUG resistance in bacteria; PHYSIOLOGICAL effects of antibiotics
- Publication
Community Acquired Infection, 2015, Vol 2, Issue 1, p3
- ISSN
2225-6482
- Publication type
Article
- DOI
10.4103/2225-6482.153855